{"id":7618,"date":"2014-05-20T19:13:48","date_gmt":"2014-05-20T23:13:48","guid":{"rendered":"http:\/\/thundercloud.net\/infoave\/new\/?p=7618"},"modified":"2014-05-20T19:15:59","modified_gmt":"2014-05-20T23:15:59","slug":"aspirin-may-treat-cancer-but-theres-not-enough-money-in-it","status":"publish","type":"post","link":"https:\/\/www.thundercloud.net\/infoave\/new\/aspirin-may-treat-cancer-but-theres-not-enough-money-in-it\/","title":{"rendered":"Aspirin May Treat Cancer — But There’s Not Enough Money In It"},"content":{"rendered":"
\n
\n
\n

A Cancer Treatment in Your Medicine Cabinet?<\/h1>\n
\n

By\u00a0MICHELLE HOLMES<\/span>\u00a0and\u00a0<\/span>WENDY CHEN<\/span><\/span>

\n
\n
WE believe that it might be possible to treat\u00a0breast cancer<\/a>\u00a0\u2014 the leading cause of female\u00a0cancer<\/a>\u00a0death \u2014 with a drug that can already be found in nearly every medicine cabinet in the world: Aspirin.<\/div>\n

<\/p>\n

In 2010, we published an observational study in The Journal of Clinical Oncology showing that women with breast cancer who took aspirin at least once a week for various reasons were 50 percent less likely to die of breast cancer.\u00a0<\/em>In 2012, British researchers, by combining results from clinical trials that looked at using aspirin to prevent heart disease, found that aspirin was also associated with a significantly lower risk of breast cancer death.<\/p>\n

And yet, until now, there have been no randomized trials (the gold standard of research) of aspirin use among women with breast cancer.<\/p>\n

It\u2019s not hard to see why: Clinical trials are typically conducted on drugs developed by labs seeking huge profits. No one stands to make money off aspirin, which has been a generic drug since the Treaty of Versailles in 1919, and which costs less than $6 for a year\u2019s supply.<\/p>\n

Thankfully, the first randomized clinical trial is now going on in Britain, made possible by funding from a nonprofit group, Cancer Research UK. But the British study is looking at four cancers, and won\u2019t be done until 2025. If we in the United States had funding to do a similar trial, we could combine our data and get answers much faster. If the United States is to maintain its role as the global leader in biomedical research, it must fund its own trial of aspirin in breast cancer.<\/p>\n

Aspirin was originally derived from willow bark, which has been used as a painkiller since the time of Hippocrates. We don\u2019t know exactly why it appears to work in fighting cancer. Aspirin reduces inflammation, and that may play a role in inhibiting the growth of tumors \u2014 perhaps by slowing the development of new blood vessels that nourish them, or by fighting old cells that keep growing when they should be dying off. It may also inhibitestrogen<\/a>\u00a0production, and we know that estrogen fuels the growth of most (but not all) breast cancers.<\/p>\n<\/div>\n<\/blockquote>\n

Continue reading the main story: Source NY TIMES<\/a><\/span><\/strong><\/h4>\n","protected":false},"excerpt":{"rendered":"

A Cancer Treatment in Your Medicine Cabinet? By\u00a0MICHELLE HOLMES\u00a0and\u00a0WENDY CHENMAY 19, 2014 WE believe that it might be possible to treat\u00a0breast cancer\u00a0\u2014 the leading cause of female\u00a0cancer\u00a0death \u2014 with a drug that can already be found in nearly every medicine cabinet in the world: Aspirin. In 2010, we published an observational study in The Journal of Clinical Oncology\u2026 Read More »<\/a><\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1426],"tags":[],"_links":{"self":[{"href":"https:\/\/www.thundercloud.net\/infoave\/new\/wp-json\/wp\/v2\/posts\/7618"}],"collection":[{"href":"https:\/\/www.thundercloud.net\/infoave\/new\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thundercloud.net\/infoave\/new\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thundercloud.net\/infoave\/new\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thundercloud.net\/infoave\/new\/wp-json\/wp\/v2\/comments?post=7618"}],"version-history":[{"count":4,"href":"https:\/\/www.thundercloud.net\/infoave\/new\/wp-json\/wp\/v2\/posts\/7618\/revisions"}],"predecessor-version":[{"id":7622,"href":"https:\/\/www.thundercloud.net\/infoave\/new\/wp-json\/wp\/v2\/posts\/7618\/revisions\/7622"}],"wp:attachment":[{"href":"https:\/\/www.thundercloud.net\/infoave\/new\/wp-json\/wp\/v2\/media?parent=7618"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thundercloud.net\/infoave\/new\/wp-json\/wp\/v2\/categories?post=7618"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thundercloud.net\/infoave\/new\/wp-json\/wp\/v2\/tags?post=7618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}